Ruiz-Canela M, Valle-Mansilla J I, Sulmasy D P
Department of Biomedical Humanities, University of Navarra, Pamplona. Spain.
J Med Ethics. 2009 Apr;35(4):251-7. doi: 10.1136/jme.2008.025957.
The use of human samples in genomic research has increased ethical debate about informed consent (IC) requirements and the information that subjects should receive regarding the results of the research. However, there are no quantitative data regarding researchers' attitudes about these issues.
We present the results of a survey of 104 US and 100 Spanish researchers who had published genomic epidemiology studies in 61 journals during 2006.
Researchers preferred a broader IC than the IC they had actually obtained in their published papers. US authors were more likely than their Spanish colleagues to support obtaining a broad IC, covering either any future research project or any projects related to a group of diseases (67.6% vs 43%; adjusted OR = 4.84, 95% CI, 2.32 to 10.12). A slight majority of researchers (55.8%) supported informing participants about individual genomic results only if the reliability and clinical validity of the information had been established. Men were more likely than women to believe that patients should be informed of research results even if these conditions were not met (adjusted OR = 2.89, 95% CI = 1.46 to 5.72).
This study provides evidence of a wide range of views among scientists regarding some controversial ethical issues related to genomic research, suggesting the need for more study, debate and education. In the interim, journals might consider including the investigators' policies regarding these ethical issues in the papers they publish in the field of genomic epidemiology.
在基因组研究中使用人类样本引发了关于知情同意(IC)要求以及受试者应获得的研究结果相关信息的伦理辩论。然而,关于研究人员对这些问题的态度,尚无定量数据。
我们展示了对104名美国和100名西班牙研究人员的调查结果,这些研究人员在2006年期间于61种期刊上发表了基因组流行病学研究。
研究人员倾向于比他们在已发表论文中实际获得的更广泛的知情同意。美国作者比西班牙同行更有可能支持获得广泛的知情同意,涵盖任何未来的研究项目或与一组疾病相关的任何项目(67.6%对43%;调整后的OR = 4.84,95%CI,2.32至10.12)。略多数的研究人员(55.8%)支持仅在信息的可靠性和临床有效性得到确立时才告知参与者个人基因组结果。男性比女性更有可能认为即使不满足这些条件也应告知患者研究结果(调整后的OR = 2.89,95%CI = 1.46至5.72)。
本研究提供了证据,表明科学家们对与基因组研究相关的一些有争议的伦理问题存在广泛的观点,这表明需要更多的研究、辩论和教育。在此期间,期刊可能会考虑在其发表的基因组流行病学领域的论文中纳入研究人员关于这些伦理问题的政策。